Company profile

hVIVO

hVIVO - Making Innovation Possible

Industry
Biotechnology Research
Employees
237
Headquarters
London, England
Founded
1989
LinkedIn followers
14,754
Office locations
1

hVIVO company summary

hVIVO is a company in the Biotechnology Research industry, headquartered in London, England, founded in 1989. On LinkedIn the company has around 237 employees and 14,754 followers. Its listed specialties include clinical trials, uk clinical trials, clinical research, challenge models, human challenge models.

What technology does hVIVO use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About hVIVO

hVIVO plc (Ticker: HVO) is a science‑led early‑phase drug development company purpose‑built to meet the growing complexity of modern clinical research. The Company operates an integrated early‑phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‑ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With industry‑leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other high‑growth therapeutic areas, hVIVO supports a diverse global client base that includes seven of the world’s ten largest biopharmaceutical companies. Its London quarantine facilities are the largest purpose‑built human challenge units in the world, complemented by additional early‑phase clinical capacity in Germany and a specialist consulting team providing strategic, regulatory, and biometry expertise. The Company’s integrated approach delivers a seamless pathway from preclinical planning through early proof‑of‑concept, supported by continuous patient recruitment through FluCamp and a network of outpatient clinical sites for Phase II and III studies. By unifying scientific insight, operational control, and advanced laboratory capabilities, hVIVO provides sponsors with the clarity, speed, and reliability required to advance new medicines with confidence.

Specialties

clinical trialsuk clinical trialsclinical researchchallenge modelshuman challenge modelshuman volunteer researchrespiratory disease researchmedical researchasthma studiescopdinfluenzahuman models of diseaseclinical researchchallenge studieshuman challenge trialsRSVmalariaHRVRespiratory syncytial virusHuman rhinoviruselab servicescovid 19cardiometabolicphase 1regulatory writingCMCFirst in HumanProof of ConceptPKPDHematologyCardiologyDermatologyEndocrinologyMedical DevicesMetabolic DisordersDiabetesHepatologyPhase 2Hepatic ImpairmentRenal ImpairmentMASLDPreclinicalPre-clinicalFIHEarly phase clinical researchRespiratoryInfectious DiseaseAirway Disease

Where is hVIVO located?

hVIVO lists 1 location.

London, England E14 5NR, GBHQ
40 Bank Street

Compare companies similar to hVIVO

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
hVIVO
hvivo.com
Biotechnology Research2371989London, England
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about hVIVO

What does hVIVO do?

hVIVO plc (Ticker: HVO) is a science‑led early‑phase drug development company purpose‑built to meet the growing complexity of modern clinical research. The Company operates an integrated early‑phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‑ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With industry‑leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other high‑growth therapeutic areas, hVIVO supports a diverse global client base that includes seven of the world’s ten largest biopharmaceutical companies. Its London quarantine facilities are the largest purpose‑built human challenge units in the world, complemented by additional early‑phase clinical capacity in Germany and a specialist consulting team providing strategic, regulatory, and biometry expertise. The Company’s integrated approach delivers a seamless pathway from preclinical planning through early proof‑of‑concept, supported by continuous patient recruitment through FluCamp and a network of outpatient clinical sites for Phase II and III studies. By unifying scientific insight, operational control, and advanced laboratory capabilities, hVIVO provides sponsors with the clarity, speed, and reliability required to advance new medicines with confidence.

How many employees does hVIVO have?

hVIVO has around 237 employees on LinkedIn.

Where is hVIVO headquartered?

hVIVO is headquartered in London, England.

When was hVIVO founded?

hVIVO was founded in 1989.

Build a lead list from companies like hVIVO

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.